Browsing Tag
Trastuzumab Pamirtecan
1 post
BioNTech’s €16.2bn cash position cushions breast cancer drug setback as oncology spending rises
BioNTech's breast cancer drug faces lung safety concerns despite Phase 3 success. Explore its €16.2B cash reserve and oncology strategy.